Evidence map›Paper›PMID 30524948›Full record

ArticleFEBS open bio2018

Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.

Shohei Mizuno, Ichiro Hanamura, Akinobu Ota, Sivasundaram Karnan, Jo Kanasugi, Ayano Nakamura, Souichi Takasugi, Kaori Uchino, Tomohiro Horio, Mineaki Goto and 11 more

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Shohei MizunoDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Ichiro HanamuraDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.ORCID 0000-0002-6681-8927
Akinobu OtaDepartment of Biochemistry Aichi Medical University Japan.
Sivasundaram KarnanDepartment of Biochemistry Aichi Medical University Japan.
Jo KanasugiDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Ayano NakamuraDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Souichi TakasugiDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Kaori UchinoDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Tomohiro HorioDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Mineaki GotoDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Satsuki MurakamiDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Mayuko GotouDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Hidesuke YamamotoDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Masaya WataraiDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Masato ShikamiDepartment of Hematology Daiyukai General Hospital Aichi Japan.
Yoshitaka HosokawaDepartment of Biochemistry Aichi Medical University Japan.
Hiroshi MiwaDepartment of Hematology Mie University Japan.
Masafumi TaniwakiDepartment of Hematology and Oncology Graduate School of Medical Science Kyoto Prefectural University of Medicine Japan.
Ryuzo UedaDepartment of Tumor Immunology Aichi Medical University School of Medicine Japan.
Masakazu NittaDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Akiyoshi TakamiDivision of Hematology Department of Internal Medicine Aichi Medical University Japan.
Aichi Medical University · JPDaiyukai General Hospital · JPKyoto Prefectural University of Medicine · JPMie University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosome band 8q24 is the most frequently amplified locus in various types of cancers.

Indexed as

chromosome 8q24diffuse large B‐cell lymphomahomogeneously staining regionMYConcogene amplificationpatient‐derived cell line

Identifiers

PMID30524948
PMCPMC6275272
OpenAlexW2895791465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.